These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2151334)

  • 21. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.
    Yiu KH; Tse HF
    J Hum Hypertens; 2008 Jun; 22(6):380-8. PubMed ID: 18337759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
    Messerli FH; Soria F
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():557-63. PubMed ID: 7841089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac hypertrophy in hypertension--clinical significance and possibilities of control].
    Widimský J
    Cor Vasa; 1993; 35(2):84-9. PubMed ID: 8500300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular hypertrophy: impact of calcium channel blocker therapy.
    Messerli FH
    Am J Med; 1991 May; 90(5A):27S-31S. PubMed ID: 2039017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular hypertrophy.
    Jones JV; James MA; MacConnell TJ
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():35-9; discussion 39-40. PubMed ID: 1838775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
    Messerli FH
    Blood Press Suppl; 1992; 1():35-6; discussion 37. PubMed ID: 1343271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
    Novo S; Abrignani MG; Corda M; Strano A
    Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.
    Devereux RB; Roman MJ
    J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Messerli FH; Soria F
    Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk reduction following regression of cardiac hypertrophy.
    Schmieder RE
    Clin Exp Hypertens A; 1990; 12(5):903-16. PubMed ID: 2145097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertensive cardiopathy and arrhythmias].
    López Gil M; Arribas F; Velázquez MT; Casas P
    Rev Esp Cardiol; 1997; 50 Suppl 4():68-73. PubMed ID: 9411591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.